DEC 19, 2018 6:51 PM PST

UTI Infection Becoming a Common Reoccurrence?

WRITTEN BY: Nicholas Breehl

A Urinary tract infection (UTI) is one reason many patients take a trip to visit their physician. Upon clearing of the infection, some individuals find that the annoyance has returned and rather quickly, leaving them questioning the effectiveness of the treatment. In a recent study published in the scientific journal known as PLOS Pathogens, a team of researchers sheds light on what could be going on.

A urinary tract infection is an infection in any part of your urinary system —  kidneys, ureters, bladder, and urethra. Most infections involve the lower urinary tract — the bladder and the urethra.

Women are at higher risk of developing a UTI than are men. Infection limited to your bladder can be painful and annoying. However, serious consequences can occur if a UTI spreads to your kidneys.

Urinary tract infections are widespread and can be highly recurrent, with 1–2% of women suffering from six or more frequent episodes per year. The high incidence of recurrent UTI, including recurrent infections caused by the same bacterial strain that produced the first infection, suggests that at least some women do not mount a protective adaptive immune response to UTI.

Many patients suffer from highly recurrent urinary tract infections caused by Escherichia coli, which are genetically diverse bacteria. Recurrent episodes are often caused by the same E. coli strain that created the first infection, suggesting that some patients may not develop a protective immune response.

The researchers, making use of bladder infected mouse models, discover that two E. coli strains behave differently. One strain, known as UTI89, infects the bladder indefinitely, whereas another strain called CFT073 is cleared within eight weeks.

Interestingly, mice which had already been exposed to CFT073 and treated with antibiotics were henceforth protected from reinfection, however, remained susceptible to UTI89 infection. In contrast to this finding, mice with a UTI89 infection and antibiotics were susceptible to recurrent UTI when challenged with either strain.

“We found that depleting T cells, immune cells important for developing protection against infection prevented mice from clearing their CFT073 infections and made them susceptible to recurrent CFT073 UTI. Thus, while infection with one E. coli strain could trigger a protective immune response, another strain sidestepped this response” shares authors of the publication.

“Our findings demonstrate the complex interplay between the broad genetic diversity of UPEC and the host innate and adaptive immune responses during UTI. A better understanding of these host-pathogen interactions is urgently needed for effective drug and vaccine development in the era of increasing antibiotic resistance,” shares the authors of the study.

The findings to this study shed new light on immune responses to UTI and may be essential for drug and vaccine development.

Sources: PLOS Pathogen, Mayo Clinic, YouTube

About the Author
You May Also Like
AUG 05, 2020
Coronavirus
Age-old Immune Components Affecting COVID-19 Severity
AUG 05, 2020
Age-old Immune Components Affecting COVID-19 Severity
One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to expe ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
OCT 28, 2020
Microbiology
Immune Cells Link Gum Disease to Inflammatory DIsorders
OCT 28, 2020
Immune Cells Link Gum Disease to Inflammatory DIsorders
Scientists and clinicians know that oral health and inflammation, which is a part of many diseases, are connected.
NOV 05, 2020
Immunology
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
NOV 05, 2020
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
Our knowledge of COVID-19 or SARS-CoV-2 is increasing every day, with new research papers published continuously. Resear ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
Loading Comments...